Screener
CONMED CNMD Treasury Stock
Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| authorized 500,000 shares; none outstanding | — | — |
| Common stock, par value $0.01 per share;100,000,000 shares authorized; 31,299,194 sharesissued in 2026 and 2025, respectively | 313 | 313 |
| Paid-in capital | 513,464 | 503,200 |
| Retained earnings | 625,665 | 588,766 |
| Accumulated other comprehensive loss | (43,372) | (46,295) |
| Less: 1,312,367 and 328,097 shares of common stock in treasury, at cost, in 2026 and 2025, respectively | (54,680) | (12,887) |
| Total shareholders’ equity | 1,041,390 | 1,033,097 |
| Total liabilities and shareholders’ equity | $2,300,306 | $2,325,749 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's treasury stock?
- CONMED (CNMD) reported treasury stock of $54.68M in Q2 2026.
- How has CONMED's treasury stock changed year-over-year?
- CONMED's treasury stock increased by 294.5% year-over-year, from $13.86M to $54.68M.
- What is the long-term trend for CONMED's treasury stock?
- Over 5 years (2020 to 2025), CONMED's treasury stock has grown at a -28.2% compound annual growth rate (CAGR), from $67.64M to $12.89M.
- What does treasury stock mean?
- Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.
Ask your AI about CONMED's treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude